Novelion Therapeutics Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Vancouver British Columbia Canada (1981)
Status: Acquired by Amryt Research Limited (2019) → now Chiesi (2023)

Organization Overview

First Clinical Trial
2000
NCT00007969
First Marketed Drug
2012
lomitapide (juxtapid)
First NDA Approval
2012
lomitapide (juxtapid)
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Aegerion | AEGERION | Aegerion Pharmaceuticals | Aegerion Pharmaceuticals, Inc. | QLT | QLT Inc | QLT Inc. | QLT Phototherapeutics | QLT USA, Inc | QLT USA, Inc.